Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 23, 2015
Recipharm has entered into the previously announced strategic collaboration with Alcon, a Novartis company, and has signed a long term supply agreement whereby Recipharm will manufacture a range of ophthalmic products using Blow Fill Seal technology.
read more
Monday, December 28, 2015
Seattle Genetics, Inc. and Bristol-Myers Squibb have announced that the companies have initiated a phase 1/2 clinical trial of ADCETRIS (brentuximab vedotin) in combination with Opdivo (nivolumab) for patients with CD30-expressing relapsed or ...
read more
Monday, December 28, 2015
PharMEDium Services, LLC, a part of AmerisourceBergen, announced the recent certification of its Customer Service Center as a Center of Excellence by BenchmarkPortal. The Center of Excellence recognition is one of the most prestigious awards in the ...
read more
Monday, December 28, 2015
ImmuCell Corporation , an animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, has entered into a Product Development & Contract Manufacture ...
read more
Monday, December 28, 2015
GlaxoSmithKline has announced the completion of its transaction to divest its rights to ofatumumab for auto-immune indications to Novartis Pharma AG, a subsidiary of Novartis AG, following regulatory approval.
read more
Monday, December 28, 2015
Agenus Inc., an immunotherapy company developing innovative treatments for cancer, today announced that it has acquired privately-held PhosImmune Inc., a company that has discovered an entirely new portfolio of cancer neoantigens.
read more
Monday, December 28, 2015
Galapagos NV and Gilead Sciences, Inc. have entered into a global partnership for the development and commercialization of the JAK1-selective inhibitor filgotinib for inflammatory disease indications.
read more
Tuesday, December 29, 2015
Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, announced that it has acquired all of the remaining rights, title and interest in and ...
read more
Tuesday, December 29, 2015
Biotechnology companies continue to forge ahead with advancing clinical trials and development of next-generation treatments for rare diseases through new orphan drug designations and cutting edge drug delivery products.
read more
Tuesday, December 29, 2015
Pfizer Inc. today announced that it has completed its acquisition of Hospira, Inc.
read more
Tuesday, December 29, 2015
PixarBio Corporation announced today the appointment of Steven Chartier as V.P. of Regulatory Affairs.
read more
Tuesday, December 29, 2015
Epizyme, Inc., has announced that the U.S. Food and Drug Administration’s (FDA) Division of Hematology Products has accepted the company’s investigational new drug (IND) application for tazemetostat for the treatment of adults with diffuse large B-...
read more
Tuesday, December 29, 2015
Ash Stevens’ Riverview manufacturing facility is pleased to announce it has been recognized for exemplary efforts in improving its environmental, health, safety and security (EHS&S) operations by the Society of Chemical Manufacturers and Affiliates (...
read more
Tuesday, December 29, 2015
CMC Biologics, Inc. today announced that they have entered into an agreement with Immunocore Limited, a leading UK-based biotechnology company focused on developing new treatments for cancer, viral infections and autoimmune diseases, for the process ...
read more
Tuesday, December 29, 2015
Roughly half of all surveyed global and U.S. pharmaceutical teams report involving key opinion leader (KOL) management or medical science liaison (MSL) teams in their investigator-initiated trial (IIT) proposal collection processes.
read more